|
|
|
Volumn 24, Issue 4 Suppl 12, 1997, Pages
|
|
Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
PACLITAXEL;
RADIOSENSITIZING AGENT;
CLINICAL TRIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MULTIMODALITY CANCER THERAPY;
REVIEW;
SMALL CELL CARCINOMA;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
CISPLATIN;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
|
|
EID: 0031201660
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (63)
|